Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript - Thomson StreetEvents

Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript - Thomson StreetEvents
Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Published Mar 04, 2025
9 pages (5404 words) — Published Mar 04, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PVLA.OQ presentation 4-Mar-25 7:30pm GMT

  
Brief Excerpt:

...We're going to go ahead and get started. Thanks everyone for joining us for the Palvella Therapeutics presentation and guided Q&A. I am covering analyst, Ritu Baral. With us from Palvella to present the story and with us during Q&A are going to be founder and CEO, Wes Kaupinen. Wes. Wesley Kaupinen ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Palvella Therapeutics Inc
Ticker
PVLA.OQ
Time
7:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Ritu Baral - TD Cowen - Analyst : So, Wes -- sorry, I'm covering analyst Ritul Baral with TD Cowen. Maybe you can talk to us a little bit about your conversations with the FDA on the trial design and the novel endpoint for this SELVA study, their understanding of the unmet need, and their buy-in as it stands, understanding that they never give final buy-in until you get the effect size and blah, blah, blah.

Question: Ritu Baral - TD Cowen - Analyst : So alongside -- you're going to make your announcement about additional indications later. But how are you thinking about the strategy behind additional indications? You're going to keep specializing in rare derm, but what are other characteristics of the indications that makes sense for Palvella? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MARCH 04, 2025 / 7:30PM, PVLA.OQ - Palvella Therapeutics Inc at TD Cowen Healthcare Conference

Question: Ritu Baral - TD Cowen - Analyst : Competi -- so little to no competition.

Question: Ritu Baral - TD Cowen - Analyst : And then, what other molecules are you investigating as future candidates? What are some of the biochemical features that best fit with QTORIN or best fit with QTORIN versus any other formulation technology?

Question: Ritu Baral - TD Cowen - Analyst : And besides the QTORIN platform, are there any other in-house R&D currently underway?

Question: Ritu Baral - TD Cowen - Analyst : Great. Thank you, Wes. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MARCH 04, 2025 / 7:30PM, PVLA.OQ - Palvella Therapeutics Inc at TD Cowen Healthcare Conference

Table Of Contents

Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript – 2025-09-24 – US$ 54.00 – Edited Transcript of PVLA.OQ corporate analyst meeting</ 24-Sep-25 12:30pm GMT

Palvella Therapeutics Inc Q2 2025 Earnings Call Transcript – 2025-08-14 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 14-Aug-25 12:30pm GMT

Palvella Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of PVLA.OQ shareholder or annual meeting 10-Jun-25 3:00pm GMT

Palvella Therapeutics Inc Q1 2025 Earnings Call Transcript – 2025-05-15 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 15-May-25 12:30pm GMT

Palvella Therapeutics Inc Q4 2024 Earnings Call Transcript – 2025-03-31 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 31-Mar-25 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript" Mar 04, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Palvella-Therapeutics-Inc-at-TD-Cowen-Healthcare-Conference-T16273426>
  
APA:
Thomson StreetEvents. (2025). Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript Mar 04, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Palvella-Therapeutics-Inc-at-TD-Cowen-Healthcare-Conference-T16273426>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.